These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 32423281)

  • 1. H
    Kato Y; Ohishi T; Sano M; Asano T; Sayama Y; Takei J; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Jun; 39(3):61-65. PubMed ID: 32423281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H
    Kato Y; Ohishi T; Yamada S; Itai S; Takei J; Sano M; Nakamura T; Harada H; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2019 Aug; 38(4):157-161. PubMed ID: 31199696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Antihuman Epidermal Growth Factor Receptor 2 Monoclonal Antibody (H
    Kato Y; Ohishi T; Takei J; Nakamura T; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):135-139. PubMed ID: 32644843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of H
    Yamada S; Itai S; Nakamura T; Chang YW; Harada H; Suzuki H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):287-290. PubMed ID: 29172998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Anti-HER2 Monoclonal Antibody H
    Tateyama N; Asano T; Ohishi T; Takei J; Hosono H; Nanamiya R; Tanaka T; Sano M; Saito M; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):184-190. PubMed ID: 34424760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Anti-Human Epidermal Growth Factor Receptor 2 Monoclonal Antibody H
    Kato Y; Ohishi T; Takei J; Nakamura T; Sano M; Asano T; Sayama Y; Hosono H; Kawada M; Kaneko MK
    Monoclon Antib Immunodiagn Immunother; 2020 Aug; 39(4):123-128. PubMed ID: 32552424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of an Anti-HER2 Monoclonal Antibody H2Mab-139 Against Colon Cancer.
    Kaneko MK; Yamada S; Itai S; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2018 Feb; 37(1):59-62. PubMed ID: 29315012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Cancer-Specific Monoclonal Antibody against HER2 Exerts Antitumor Activities in Human Breast Cancer Xenograft Models.
    Kaneko MK; Suzuki H; Ohishi T; Nakamura T; Tanaka T; Kato Y
    Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H
    Takei J; Kaneko MK; Ohishi T; Kawada M; Harada H; Kato Y
    Exp Ther Med; 2020 Aug; 20(2):846-853. PubMed ID: 32765652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HER2 Cancer-Specific mAb, H
    Suzuki H; Ohishi T; Tanaka T; Kaneko MK; Kato Y
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39125956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defucosylated Monoclonal Antibody (H
    Suzuki H; Ohishi T; Nanamiya R; Kawada M; Kaneko MK; Kato Y
    Curr Issues Mol Biol; 2023 Sep; 45(10):7734-7748. PubMed ID: 37886932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a Novel Cancer-Specific Anti-HER2 Monoclonal Antibody H
    Kaneko MK; Suzuki H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):35-43. PubMed ID: 38563783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of a monoclonal antibody targeting major histocompatibility complex class I-Her2 peptide complexes.
    Jain R; Rawat A; Verma B; Markiewski MM; Weidanz JA
    J Natl Cancer Inst; 2013 Feb; 105(3):202-18. PubMed ID: 23300219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H
    Itai S; Fujii Y; Kaneko MK; Yamada S; Nakamura T; Yanaka M; Saidoh N; Chang YW; Handa S; Takahashi M; Suzuki H; Harada H; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2017 Aug; 36(4):143-148. PubMed ID: 28700270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of a combination of trastuzumab (Herceptin) and oral fluoropyrimidine S-1 on human epidermal growth factor receptor 2-overexpressing pancreatic cancer.
    Saeki H; Yanoma S; Takemiya S; Sugimasa Y; Akaike M; Yukawa N; Rino Y; Imada T
    Oncol Rep; 2007 Aug; 18(2):433-9. PubMed ID: 17611667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor Activities in Mouse Xenograft Models of Canine Fibroblastic Tumor by Defucosylated Mouse-Dog Chimeric Anti-HER2 Monoclonal Antibody (H77Bf).
    Suzuki H; Asano T; Ohishi T; Yoshikawa T; Suzuki H; Mizuno T; Tanaka T; Kawada M; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2023 Feb; 42(1):34-40. PubMed ID: 36383106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Novel Anti-HER2 Monoclonal Antibody H
    Takei J; Asano T; Tanaka T; Sano M; Hosono H; Nanamiya R; Tateyama N; Saito M; Suzuki H; Harada H; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2021 Aug; 40(4):168-176. PubMed ID: 34424764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibody.
    Huang S; Li F; Liu H; Ye P; Fan X; Yuan X; Wu Z; Chen J; Jin C; Shen B; Feng J; Zhang B
    MAbs; 2018; 10(6):864-875. PubMed ID: 30081724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of HER2 by gemcitabine enhances the antitumor effect of combined gemcitabine and trastuzumab emtansine treatment on pancreatic ductal adenocarcinoma cells.
    Kan S; Koido S; Okamoto M; Hayashi K; Ito M; Kamata Y; Komita H; Nagasaki E; Homma S
    BMC Cancer; 2015 Oct; 15():726. PubMed ID: 26475267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1.
    Ogitani Y; Aida T; Hagihara K; Yamaguchi J; Ishii C; Harada N; Soma M; Okamoto H; Oitate M; Arakawa S; Hirai T; Atsumi R; Nakada T; Hayakawa I; Abe Y; Agatsuma T
    Clin Cancer Res; 2016 Oct; 22(20):5097-5108. PubMed ID: 27026201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.